Benzinga's Top Upgrades, Downgrades For April 17, 2017

Loading...
Loading...

Top Upgrades

  • Wells Fargo upgraded McDonald's Corporation MCD from Market Perform to Outperform. McDonald's shares rose 0.72 percent to $131.70 in pre-market trading.
  • Stifel Nicolaus upgraded Valmont Industries, Inc. VMI from Hold to Buy. Valmont shares fell 1.12 percent to close at $146.30 on Thursday.
  • Raymond James upgraded S&P Global Inc SPGI from Market Perform to Outperform. S&P Global shares fell 0.50 percent to close at $128.28 on Thursday.
  • Analysts at Baird upgraded Knight Transportation KNX from Neutral to Outperform. Knight Transportation shares fell 1.12 percent to close at $31.00 on Thursday.
  • Analysts at Stifel Nicolaus upgraded CIRCOR International, Inc. CIR from Hold to Buy. CIRCOR shares dropped 0.07 percent to close at $56.14 on Thursday.
  • Wells Fargo upgraded Cummins Inc. CMI from Market Perform to Outperform. Cummins shares fell 1.6 percent to close at $144.57 on Thursday.


Top Downgrades

  • Analysts at PiperJaffray downgraded Incyte Corporation INCY from Overweight to Neutral. Incyte shares fell 10.54 percent to $126.00 in pre-market trading.
  • Morgan Stanley downgraded Eli Lilly and Co LLY from Overweight to Equal-Weight. Eli Lilly shares dropped 5.6 percent to $81.11 in pre-market trading.
  • Susquehanna downgraded KLA-Tencor Corp KLAC from Neutral to Negative. KLA-Tencor shares rose 0.13 percent to close at $95.33 on Thursday.
  • Analysts at FBR Capital downgraded Ability Inc ABIL from Outperform to Market Perform. Ability shares closed at $1.21 on Thursday.
  • Analysts at BMO Capital downgraded Eli Lilly and Co LLY from Market Perform to Underperform. Eli Lilly shares dropped 5.6 percent to $81.11 in pre-market trading.
  • Deutsche Bank downgraded Sociedad Quimica y Minera de Chile (ADR) SQM from Buy to Hold. Sociedad Quimica y Minera shares rose 0.03 percent to $37.00 in pre-market trading.


Top Initiations

  • Analysts at BMO Capital initiated coverage on Alnylam Pharmaceuticals, Inc. ALNY with a Outperform rating. The price target for Alnylam Pharmaceuticals is set to $73. Alnylam Pharmaceuticals shares closed at $49.85 on Thursday.
  • Analysts at BMO Capital initiated coverage on Halozyme Therapeutics, Inc. HALO with a Market Perform rating. The price target for Halozyme Therapeutics is set to $14. Halozyme Therapeutics shares closed at $12.81 on Thursday.
  • Analysts at Cowen & Co. initiated coverage on Valeritas Holdings, Inc. VLRX with a Outperform rating. Valeritas shares closed at $6.30 on Thursday.
  • Analysts at Axiom Capital initiated coverage of Canadian Solar Inc. CSIQ with a Buy rating. The price target for Canadian Solar is set to $18. Canadian Solar shares closed at $12.72 on Thursday.
  • Analysts at Macquarie initiated coverage of Himax Technologies, Inc. (ADR) HIMX with a Outperform rating. The price target for Himax Technologies is set to $12. Himax Technologies shares closed at $8.40 on Thursday.
  • Analysts at Goldman Sachs initiated coverage on Integrated Device Technology Inc IDTI with a Neutral rating. The price target for Integrated Device Technology is set to $24. Integrated Device Technology shares closed at $23.24 on Thursday.
  • Analysts at Craig-Hallum initiated coverage on Merit Medical Systems, Inc. MMSI with a Buy rating. The price target for Merit Medical Systems is set to $36. Merit Medical Systems shares closed at $28.20 on Thursday.
Loading...
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: UpgradesDowngradesInitiationAnalyst RatingsConsumer DiscretionaryDowngradesInitiationsRestaurantstop upgrades
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...